SOX17 expression is maintained in a restricted fashion in the adult endothelium, but increases in response to inflammatory or hypoxic signaling and deficiencies in expression appear to increase the likelihood of endothelial dysfunction and subsequent PAH. This evidence concerns the gene SOX17 and pulmonary arterial hypertension.